Patient Square Capital LP Portfolio Holdings

Patient Square Capital LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $267 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $148B, Liquidia Corp with a value of $21.9B, Insmed Inc with a value of $21.2B, Cullinan Oncology, Inc. with a value of $10.7B, and Eye Point Pharmaceuticals, Inc. with a value of $10.5B.

Examining the 13F form we can see an decrease of $2.04B in the current position value, from $269B to 267B.

Patient Square Capital LP is based out at Menlo Park, CA

Below you can find more details about Patient Square Capital LP portfolio as well as his latest detailed transactions.